These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory. Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753 [TBL] [Abstract][Full Text] [Related]
10. N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda. Velthuis HT; Knop I; Stam P; van den Broek M; Bos HK; Hol S; Teunissen E; Fischedick KS; Althaus H; Schmidt B; Wagner C; Melsert R Clin Chem Lab Med; 2011 Aug; 49(8):1323-1332. PubMed ID: 21663464 [TBL] [Abstract][Full Text] [Related]
11. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Jaskowski TD; Litwin CM; Hill HR Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338 [TBL] [Abstract][Full Text] [Related]
12. Serum free light chain reference values: a critical approach. Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536 [TBL] [Abstract][Full Text] [Related]
13. Analytical performance of the serum free light chain assay. Briand PY; Decaux O; Caillon H; Grosbois B; Le Treut A; Guenet L Clin Chem Lab Med; 2010; 48(1):73-9. PubMed ID: 19929752 [TBL] [Abstract][Full Text] [Related]
14. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population. Abadie JM; Bankson DD Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511 [TBL] [Abstract][Full Text] [Related]
15. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies. Wood PB; McElroy YG; Stone MJ Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664 [TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy]. Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013 [TBL] [Abstract][Full Text] [Related]
18. Verification of serum reference intervals for free light chains in a local South African population. Zemlin AE; Rensburg MA; Ipp H; Germishuys JJ; Erasmus RT J Clin Pathol; 2013 Nov; 66(11):992-5. PubMed ID: 23801498 [TBL] [Abstract][Full Text] [Related]
19. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy. Wolff F; Thiry C; Willems D Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]